Company ProfilePremium

AVNS

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
AVNS - Healthcare showcase

Year Founded & Workforce

2014

5,380 Employees

Industry

Healthcare

Services

Peripheral Nerve StimulatorsCPNB CathetersPain Pumps
A

AVNS Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AVNS Overview

Company Headquarters: Georgia, US

Founded: 2014

Workforce: ~5,380

Company Working: AVNS (Avanos Medical, Inc) is a manufacturer and distributor of medical devices. The company's products include endotracheal tubes, adult, neonatal, and pediatric closed suction systems, oral hygiene products, and catheters for collecting bronchial aspirate samples. Furthermore, it offers medically superior products and services for IV therapy, pain management, infection control, and digestive health. In addition to other nations, it has factories in France, Tunisia, the US, and Mexico. The company sells its medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Moreover, the company has its operations in the US Australia, China, India, New Zealand, and France.

Strategy

AVNS focused on strengthening its manufacturing presence through R&D investments to accomplish a sustainable pipeline that will deliver value near and long term. The company focused on offering patient’s revolutionary solutions that are clinically superior. It also concentrated on promoting changes in the medical device sector to lessen the use of pain management and chronic care devices while assisting patients in recovering more quickly and living better lives. Furthermore, it is also focused on chronic care and pain management product offerings to improve patient outcomes and reduce the cost of care.

Company Snapshot

$697.6M

Revenue

5,380

Employees

2014

Founded

Georgia, US

Headquarters

SWOT Analysis

Strengths

  • Global presence is in over 90 countries
  • Enhanced product portfolio
  • Extensive R&D capabilities
  • Wide distribution network

Weaknesses

  • Dependent on limited business segment
  • Controversies and legal issues

Opportunities

  • Expansion in small and mid-sized business markets
  • Strategic mergers and acquisitions
  • Growth opportunities in peripheral nerve stimulators business

Threats

  • Intense competition
  • Pricing pressure from government in various regions

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • AVNS
    • Peripheral Nerve Stimulators
    • CPNB Catheters
    • Pain Pumps

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 697.6 Mn in 2019 to USD 744.6 Mn in 2021.
AVNS — By Business Segment
Series (USD Mn)201920202021
Sales697.6714.8744.6
R&D37.734.932.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.